Blog
Analysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Rhythm Pharmaceuticals, Inc. (RYTM) reports results for the quarter ended March 2026. While this widely-known
Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings Growth
Rigel Pharmaceuticals (RIGL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on lower revenues when Arcus Biosciences, Inc. (RCUS) reports results for the quarter ended March 2026. While this widely-known consensus
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when QuidelOrtho (QDEL) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Ultragenyx (RARE) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Ferrari (RACE) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Ferrari (RACE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Neurocrine Biosciences (NBIX) reports results for the quarter ended March 2026. While this widely-known consensus
Earnings Preview: National CineMedia (NCMI) Q1 Earnings Expected to Decline
National CineMedia (NCMI) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Earnings Preview: Paypal (PYPL) Q1 Earnings Expected to Decline
Paypal (PYPL) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a
Onto Innovation (ONTO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Onto Innovation (ONTO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
OPENLANE (OPLN) Reports Next Week: Wall Street Expects Earnings Growth
The market expects OPENLANE (OPLN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Pan American Silver (PAAS) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Pan American Silver (PAAS) reports results for the quarter ended March 2026. While this widely-known consensus
Lumentum (LITE) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Lumentum (LITE) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Match Group (MTCH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Match Group (MTCH) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Lumen (LUMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year increase in earnings on lower revenues when Lumen (LUMN) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important
Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Myriad Genetics (MYGN) reports results for the quarter ended March 2026. While this widely-known consensus outlook
Earnings Preview: Ingredion (INGR) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Ingredion (INGR) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jazz Pharmaceuticals (JAZZ) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Intrusion Inc. (INTZ) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Intrusion Inc. (INTZ) reports results for the quarter ended March 2026. While this widely-known consensus outlook
Leidos (LDOS) Expected to Beat Earnings Estimates: Should You Buy?
Leidos (LDOS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a
Lucid Group (LCID) Expected to Beat Earnings Estimates: Should You Buy?
Lucid Group (LCID) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Idexx Laboratories (IDXX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Henry Schein (HSIC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Huron Consulting (HURN) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Huron Consulting (HURN) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Integra LifeSciences (IART) reports results for the quarter ended March 2026. While this widely-known